• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number WS6040
Device Problem Difficult to Open or Close (2921)
Patient Problems Stroke/CVA (1770); Muscle Weakness (1967); Speech Disorder (4415); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/05/2023
Event Type  Injury  
Event Description
Heal-laa study with patient identifier (b)(6).It was reported that a device failure to seal occurred.Prior to the index procedure, heparin was administered.In (b)(6) 2023, a left atrial appendage (laa) closure procedure was performed using a 40mm watchman flx pro laa closure device (wds) with a complete laa seal and deployed device diameter of 36 mm.The patient was discharged with aspirin and apixaban.In december 2023, during a routine 45-day follow-up examination, transesophageal echocardiogram (tee) identified the closure device was positioned at the laa ostium with the maximum diameter plane of the closure device within 2mm of the desired ostial plane.Additionally, a peri-device leak measuring 4mm was observed.The patient was instructed to discontinue apixaban and begin clopidogrel.
 
Event Description
Heal-laa study with patient identifier (b)(6).It was reported that a device failure to seal occurred.Prior to the index procedure, heparin was administered.In october 2023, a left atrial appendage (laa) closure procedure was performed using a 40mm watchman flx pro laa closure device (wds) with a complete laa seal and deployed device diameter of 36 mm.The patient was discharged with aspirin and apixaban.In december 2023, during a routine 45-day follow-up examination, transesophageal echocardiogram (tee) identified the closure device was positioned at the laa ostium with the maximum diameter plane of the closure device within 2mm of the desired ostial plane.Additionally, a peri-device leak measuring 4mm was observed.The patient was instructed to discontinue apixaban and begin clopidogrel.It was further reported in (b)(6) 2024 the patient present to the emergency department with right sided weakness and aphasia.The patient was given a dose of tenecteplase (tnk).At the time of the event, the patient withheld on eliquis medication for two months.The patient was admitted to the hospital and underwent brain computed tomography (ct), laboratory tests, and radiographs.An ischemic stroke was diagnosed, medication was administered, and angiography without revascularization was performed.The patient was transferred to another hospital for thrombectomy procedure.Five (5) days post admittance to the hospital the patient recovered and was discharged with aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18566797
MDR Text Key333516342
Report Number2124215-2024-01220
Device Sequence Number1
Product Code NGV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/23/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberWS6040
Device Catalogue NumberWS6040
Device Lot Number0032255230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/31/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/21/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age65 YR
Patient SexFemale
Patient RaceWhite
-
-